BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haller C, Cozzio A, von Kempis J, Rubbert-Roth A. Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis. J Clin Rheumatol 2021;27:e289-90. [PMID: 32453211 DOI: 10.1097/RHU.0000000000001415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sankari SE, Van Essche C, van Pesch V. Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients. J Neurol 2021. [PMID: 34181076 DOI: 10.1007/s00415-021-10679-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kato N, Takama H, Ando Y, Yanagishita T, Ohshima Y, Ohashi W, Akiyama M, Watanabe D. Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study. Int J Dermatol 2021;60:570-8. [PMID: 33454961 DOI: 10.1111/ijd.15382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]